Latest Mergers And Acquisitions News

Corazon Mining has successfully raised $1.8 million through a placement to fast-track exploration at its Two Pools and Feather Cap gold projects in Western Australia. The funding sets the stage for maiden drilling programs in early 2026, aiming to confirm high-grade historical results.

Sunrise Energy Metals has raised A$18.865 million through a premium-priced share placement to fast-track pre-construction at its Syerston Scandium Project, reinforcing its path toward becoming a primary scandium supplier.

Jindalee Lithium has completed its 2025 drilling program at the McDermitt Lithium Project and is advancing plans to list its US subsidiary on a national exchange, extending exclusivity with its merger partner.

Mammoth Minerals has raised A$7.5 million through a placement to accelerate exploration at its high-grade Excelsior and Bella Gold Projects in Nevada, aiming to unlock significant gold potential.

Polymetals Resources has raised $34.4 million through a share placement to boost exploration and production at its Endeavor Silver Zinc Mine, attracting strong institutional demand.

Chariot Resources has amended its acquisition agreement for a Nigerian lithium portfolio, securing financing and extending the closing deadline to May 2026. The move reinforces exclusivity protections and paves the way for a smoother transaction completion.

Aureka has reported compelling high-grade gold assay results from its ongoing drilling at the Irvine Project in Victoria, revealing a newly identified Resolution Footwall Vein and extending known mineralisation beyond the current resource boundary.

QuickFee Limited has completed a $28.5 million capital return following the sale of its US Pay Now and Connect businesses, while updating its dividend policy to target regular shareholder cash distributions starting in FY26.

Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.

Control Bionics Limited is set to acquire the remaining stake in Neuro Elite Athletics, integrating the NeuroBounce athletic performance program with its EMG technology to accelerate growth in key markets.

Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.